Tag Archives: Approved

Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in Certain Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »

Category: Uncategorized

CVS + Aetna: Inflection Point in US Healthcare, Merger Approved Update

[unable to retrieve full-text content]     CVS Health’s acquisition of Aetna was approved this week by U.S. Federal regulators after months of scrutinizing the antitrust-size-market control implications of the deal. I wrote this post on the deal as an inflection point in American healthcare on 3rd December 2017 when CVS and Aetna announced their… Read More »

Category: Uncategorized

The First Marijuana Based Drug Approved by the FDA

Many months ago we wrote about the major scientific effort to find derivatives from the marijuana plant that have health benefits and will not get you stoned. We said that there is a remarkable future for some of these compounds. Well that day has arrived sooner than expected.   The FDA has just approved the… Read More »

Category: Uncategorized